The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,001–12,100 of 31,469
Smith, D. T., Carr, L. J., Dorozynski, C., & Gomashe, C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90557.2008 · Cited by 30
Zorzi, A. P., Wahi, G., Macnab, A. J., et al. (2009) · PubMed · Cited by 29
Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes
D’Alfonso, R., Marini, M. A., Frittitta, L., Sorge, R. P., Frontoni, S., Porzio, O., Mariani, L. M., Lauro, D., Gambardella, S., Trischitta, V., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020807 · Cited by 28
Gong, H., Du, Y. L., Zhong, L.-N., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-13 · Cited by 29
Chan, D. C., Nguyen, M. N., Watts, G. F., Ooi, E. M. M., & Barrett, P. H. R. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28422 · Cited by 29
Gotoh, S., Doi, Y., Hata, J., Ninomiya, T., Mukai, N., Fukuhara, M., Kamouchi, M., Kitazono, T., & Kiyohara, Y. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13698 · Cited by 29
MANDERS, R. J. F., Koopman, R., Beelen, M., Gijsen, A. P., Wodzig, W. K. W. H., Saris, W. H. M., & van Loon, L. J. C. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1079 · Cited by 32
Chien, K., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Hu, F. B. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.019 · Cited by 29
Aller, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Pacheco, D., Velasco, M. C., & Ovalle, H. F. (2012) · PubMed · Cited by 29
Makimura, H., Stanley, T. L., Suresh, C., Sousa‐Coelho, A. L. D., Frontera, W. R., Syu, S., Braun, L. R., Looby, S. E. D., Feldpausch, M. N., Torriani, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3696 · Cited by 29
NEW METABOLIC INDEX USE POTENTIALITIES IN EVALUATION OF INSULIN RESISTANCE IN CLINICAL PRACTICE
Roytberg, G. Е., Dorosh, J. V., Sharkhun, O. O., et al. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-3-264-274 · Cited by 29
Xu, M., Bi, Y., Huang, Y. F., Xie, L., Hao, M., Zhao, Z., Xu, Y., Lu, J., Chen, Y., Sun, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.032 · Cited by 29
Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia
Poveda, N. E., Garcés, M. F., Ruíz-Linares, C. E., et al. (2016) · Scientific Reports · doi:10.1038/srep20073 · Cited by 29
Bissell, L.-A., Hensor, E. M. A., Kozera, Ł., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H. I., Villeneuve, É., Donica, H., Buch, M. H., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kew306 · Cited by 31
Selvakumar, P., Kabbany, M., Lopez, R., Tozzi, G., Alisi, A., Alkhouri, N., & Nobili, V. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.04.014 · Cited by 28
Temizkan, Ş., Balaforlou, B., Özderya, A., Avcı, M., Aydın, K., Karaman, S., & Sargin, M. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13095 · Cited by 30
Hung, S.-C., Tseng, W.-T., & Pan, T. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.04.033 · Cited by 29
Villamor, E., Finan, C., Ramírez‐Zea, M., Roman, A. V., & for the Nine Mesoamerican Countries Metabolic Syndrome Study (NiMeCoMeS) Group (2016) · Public Health Nutrition · doi:10.1017/s1368980016002342 · Cited by 29
Lim, S. K., Han, K. A., Yu, J., Chamnan, P., Kim, E. S., Yoon, K., Kwon, S. H., Moon, M. K., Lee, K. W., Kim, D., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12787 · Cited by 29
Ekström, E., Lindström, E., Raqib, R., Arifeen, S. E., Basu, S., Brismar, K., Selling, K. E., & Persson, L. Å. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw199 · Cited by 30
Boyer, W. R., Wolff‐Hughes, D. L., Bassett, D. R., Churilla, J. R., & Fitzhugh, E. C. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.160159 · Cited by 29
Lima, J. G., Nóbrega, L. H. C., de Lima, N. N., dos Santos, M. C. F., Baracho, M. D. F. P., Bandeira, F. A. F., Ferreira, L. C., Neto, F. P. F., & Jerônimo, S. M. B. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.10.002 · Cited by 29
Andreozzi, F., Mannino, G. C., Perticone, M., Perticone, F., & Sesti, G. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.020 · Cited by 30
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study
Uygun, A., Öztürk, K., Demirci, H., Öztuna, A., Eren, F., Kozan, S., Yilmaz, Y. N., Kurt, Ö., Türker, T., Vatansever, S., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000813 · Cited by 30
Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women
Liang, X., Margolis, K. L., HENDRYX, M. S., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0761 · Cited by 29
García–Álvarez, M., Berenguer, J., Jiménez‐Sousa, M. Á., Tenor, D. P., Aldámiz‐Echevarría, T., Tejerina, F., Díez, C., Vázquez‐Morón, S., & Resino, S. (2017) · Scientific Reports · doi:10.1038/srep41516 · Cited by 31
Tirado, R., Masdeu, M. J., Vigil, L., Rigla, M., Luna, A., Rebasa, P., Pareja, R., Hurtado, M., & Caixàs, A. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2635-4 · Cited by 29
Qin, L., Zhang, W., YANG, Z. K., Niu, Y., Li, X., Lü, S., Xing, Y., Lin, N., Zhang, H., Ning, G., et al. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0168-4 · Cited by 32
Impact of obesity on metabolic syndrome components and adipokines in prepubertal children
Madeira, I. R., Carvalho, C. N. D. M., Gazolla, F. M., et al. (2009) · Jornal de Pediatria · doi:10.2223/jped.1873 · Cited by 29
Dai, X., Okon, I. S., Liu, Z., Bédarida, T., Wang, Q., Ramprasath, T., Zhang, M., Song, P., & Zou, M. (2017) · Diabetes · doi:10.2337/db17-0132 · Cited by 29
Kim, G., Oh, S. W., Jin, S., Hur, K. Y., Kim, J. H., & Lee, M. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1353080 · Cited by 30
Polyphenols activate energy sensing network in insulin resistant models
KRISHNAMOORTHY, R., & Anuradha, C. V. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.016 · Cited by 31
Diniz, B. S., Fisher‐Hoch, S. P., & McCormick, J. B. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4792 · Cited by 29
Mortensen, M. W., Spagner, C., Cuparencu, C., Astrup, A. V., Raben, A., & Dragsted, L. O. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1550-8 · Cited by 29
Valdés, E., Sepúlveda-Martínez, Á., Paula Candia, P., Abusada, N., Orellana, R., Manukian, B., & Cuellar, E. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13477 · Cited by 30
Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents
Geffner, M. E., Patel, K., Jacobson, D. L., Wu, J. W., Miller, T. L., Hazra, R., Gerschenson, M., Sharma, T. S., Silió, M., Jao, J. K., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001731 · Cited by 29
Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
Fujita, Y., Kozawa, J., Iwahashi, H., Yoneda, S., Uno, S., Eguchi, H., Nagano, H., Imagawa, A., & Shimomura, I. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12841 · Cited by 30
Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects
Kubiak, J., Thorsby, P. M., Kamycheva, E., & Jorde, R. (2018) · Endocrine Connections · doi:10.1530/ec-18-0144 · Cited by 29
Allaire, J., Vors, C., Tremblay, A. J., Marin, J., Charest, A., Tchernof, A., Couture, P., & Lamarche, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02745 · Cited by 29
Li, G., Han, L., Wang, Y., Zhao, Y., Li, Y., Fu, J., Li, M., Gao, S., & Willi, S. M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020665 · Cited by 33
Lekva, T., Godang, K., Michelsen, A. E., Qvigstad, E., Normann, K. R., Norwitz, E. R., Aukrust, P., Henriksen, T., Bollerslev, J., Roland, M. C. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31614-z · Cited by 30
Torres, A. C. M. B. G., Leite, N., Tureck, L. V., de Souza, R. L. R., Titski, A. C. K., Milano, G. E., Lazarotto, L., da Silva, L. R., & Alle, L. F. (2018) · Gene · doi:10.1016/j.gene.2018.11.065 · Cited by 32
Shah, A. M., Holter, M. M., Rimawi, F., Mark, V., Dutia, R., McGinty, J., Levin, B. L., & Laferrère, B. (2018) · Diabetes Care · doi:10.2337/dc18-1036 · Cited by 29
Clookey, S. L., Welly, R. J., Shay, D. A., Woodford, M. L., Fritsche, K. L., Rector, R. S., Padilla, J., Lubahn, D. B., & Vieira‐Potter, V. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00009 · Cited by 30
Rynarzewski, J., Dicks, L., Zimmermann, B. F., Stoffel‐Wagner, B., Ludwig, N., Helfrich, H., & Ellinger, S. (2019) · Nutrients · doi:10.3390/nu11020417 · Cited by 29
Goyal, A., Gupta, Y., Kalaivani, M., Sankar, M. J., Kachhawa, G., Bhatla, N., Gupta, N., & Tandon, N. (2019) · Diabetologia · doi:10.1007/s00125-019-4903-4 · Cited by 30
Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study
Lingaiah, S., Morin-Papunen, L. C., Risteli, J., & Tapanainen, J. S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.04.013 · Cited by 28
Kim, S., Chung, J. H., Kim, T., Lim, S. H., Kim, Y., Eun, Y., & Lee, Y.-A. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.07.020 · Cited by 30
Yasir, M., Senthilkumar, G. P., Jayashree, K., Babu, K. R., Mehalingam, V., & Chinnakali, P. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1680698 · Cited by 30
Tang, L., Tong, Y., Zhang, F., Chen, G., Zhang, Y. C., Jobin, J., & Tong, N. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0479-8 · Cited by 30
Kackley, M. L., Short, J. A., Hyde, P. N., LaFountain, R. A., Buga, A., Miller, V. J., Dickerson, R. M., Sapper, T. N., Barnhart, E. C., Krishnan, D. K., et al. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2020.1752846 · Cited by 31
Non-alcoholic fatty liver disease
Cua, I. H. Y., & George, J. (2005) · British Journal of Hospital Medicine · doi:10.12968/hmed.2005.66.2.17559 · Cited by 29
Genome‐Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study
Park, S., Li, Y., Sheng, X., Hom, V., Xia, L. Y., Zhao, K., Pooler, L., Setiawan, V. W., Lim, U., Monroe, K. R., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1533 · Cited by 30
Lampignano, L., Zupo, R., Donghia, R., Guerra, V., Castellana, F., Murro, I., Noia, C. D., Sardone, R., Giannelli, G., & Pergola, G. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241841 · Cited by 33
Renoprotective action of l ‐carnitine in fructose‐induced metabolic syndrome
Rajasekar, P., Viswanathan, P., & Anuradha, C. V. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00825.x · Cited by 29
Ohara, T., Kim, J., Asakura, M., Asanuma, H., Nakatani, S., Hashimura, K., Kanzaki, H., Funahashi, T., Tomoike, H., & Kitakaze, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.825 · Cited by 29
Halle, M., Berg, A., Frey, I., König, D., Keul, J., & Baumstark, M. W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90134-5 · Cited by 29
Chen, Y.-C., Shen, Y., Hung, Y., Chao-Ha, C., Yeh, C., & Perng, C. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.023 · Cited by 31
Koçyiğit, Y., Bayhan, G., Atamer, A., et al. (2004) · Gynecological Endocrinology · doi:10.1080/09513590410001704975 · Cited by 29
Kawamura, T., Egusa, G., Fujikawa, R., & Okubo, M. (2001) · Metabolism · doi:10.1053/meta.2001.21695 · Cited by 29
Pfützner, A., Standl, E., Hohberg, C., Konrad, T., Strotmann, H.-J., Lübben, G., Langenfeld, M. R. W., Schulze, J., & Forst, T. M. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.478 · Cited by 29
Pontiroli, A. E., Monti, L. D., Pizzini, A., & Piatti, P. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1359 · Cited by 30
Bình, T. Q., Davis, T. M. E., Johnston, W. A., et al. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90144-x · Cited by 29
Taverna, M. J., Pacher, N., Bruzzo, F., et al. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00534.x · Cited by 29
Adiponectin and Leptin in African Americans
Considine, R. V., Premkumar, A., Reynolds, J. C., Sebring, N. G., Ricks, M., & Sumner, A. E. (2008) · Obesity · doi:10.1038/oby.2007.80 · Cited by 29
Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome
Adalı, E., Kolusarı, A., Adali, F., Yıldızhan, R., Kurdoğlu, M., & Şahin, H. G. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.12.023 · Cited by 29
Impaired aortic elastic properties in young patients with prehypertension
Celık, T., Iyısoy, A., Kurşaklıoğlu, H., et al. (2006) · Blood Pressure Monitoring · doi:10.1097/01.mbp.0000209084.55364.3a · Cited by 29
Gautier, T., Tietge, U. J. F., Boverhof, R., Perton, F. G., Guern, N. L., Masson, D., Rensen, P. C. N., Havekes, L. M., Lagrost, L., & Kuipers, F. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600205-jlr200 · Cited by 29
Meshkani, R., Taghikhani, M., Larijani, B. A., Bahrami, Y., Khatami, S., Khoshbin, E., Ghaemi, A., Sadeghi, S., Mirkhani, F., Molapour, A., et al. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.095 · Cited by 29
Gao, H., Xiao, W., Wang, C., Zhang, J., Yang, Y., Yang, J. O., Yang, W., & Hong, T. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01733.x · Cited by 30
Ruane, P. J., Luber, A., Wire, M. B., Lou, Y., Shelton, M. J., Lancaster, C. T., & Pappa, K. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00560-06 · Cited by 29
Petit, J., Duong, M., Duvillard, L., Florentin, E., Portier, H., Lizard, G., Brun, J. M., Gambert, P., & Vergès, B. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00989.x · Cited by 29
Hivert, M., SULLIVAN, L. M., Shrader, P. J., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., Benjamin, E. J., & Meigs, J. B. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.017 · Cited by 29
Factors contributing to increased serum urate in postmenopausal Japanese females
Koga, M., Saito, H., Mukai, M., et al. (2009) · Climacteric · doi:10.1080/13697130802607719 · Cited by 29
Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients
Ronchi, C. L., Corbetta, S., Cappiello, V., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500663 · Cited by 29
Distribution of HOMA-IR in Brazilian subjects with different body mass indexes
Ghiringhello, M. T., Vieira, J. G. H., Tachibana, T. T., Ferrer, C., Maciel, R. M. B., Amioka, P. H. C., Hauache, O. M., Oliveira, C. H. M. C., Khawali, C., & Reis, A. F. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000300025 · Cited by 29
Sokup, A., Ruszkowska-Ciastek, B., Góralczyk, K., Walentowicz, M., Szymański, M., & Rość, D. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-21 · Cited by 31
Donahue, R. P., & Wu, T. (2001) · Annals of Periodontology · doi:10.1902/annals.2001.6.1.119 · Cited by 28
A population-based screening for gestational diabetes mellitus in non-diabetic women in Bahrain
Al Mahroos, S., Nagalla, D. S., Yousif, W., & Sanad, H. (2005) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2005.129 · Cited by 29
Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Chu, C.-H., Lee, J., Keng, H.-M., et al. (2006) · PubMed · Cited by 29
Bhattacharya, A., Rahman, M. M., McCarter, R., O’Shea, M., & Fernandes, G. (2006) · Lipids · doi:10.1007/s11745-006-5117-3 · Cited by 29
β‐cell deterioration – prospects for reversal or prevention
Finegood, D. T., & Topp, B. G. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00030.x · Cited by 28
Brun, J. ‐., de Mauverger, É. R., & Mercier, J. G. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1037 · Cited by 29
O’Dea, K., & Rowley, K. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00195-7 · Cited by 29
Dowse, G. K., Qin, H., Collins, V. R., Zimmet, P., Alberti, K. G. M. M., & Gareeboo, H. (1990) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(90)90070-a · Cited by 28
Scaglioni, S., Verduci, E., Salvioni, M., Biondi, M. L., Radaelli, G., Agostoni, C. V., & Giovannini, M. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000238259.41560.00 · Cited by 28
Shimada, K., Miyauchi, K., Mokuno, H., Miyazaki, T., Seki, E., Watanabe, Y., Iwama, Y., Shigekiyo, M., Matsumoto, M., Okazaki, S., et al. (2002) · Japanese Heart Journal · doi:10.1536/jhj.43.85 · Cited by 29
Schutte, A. E., Shemesh, T., Rowley, K., Best, J. D., McDermott, R., & O’Dea, K. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01747.x · Cited by 29
Mazza, C., Ozuna, B., Krochik, G., & Araujo, M. B. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.5.491 · Cited by 29
Hansen, A. E., Lindegaard, B., Obel, N., et al. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00334.x · Cited by 29
Alagona, C., Soro, A., Westerbacka, J., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01165.x · Cited by 29
Henry, R. R., Mudaliar, S. R. D., Chu, N. V., et al. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258657 · Cited by 29
Iribarren, C., Husson, G., Sydow, K., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000230108.86147.40 · Cited by 29
Snehalatha, C., Ramachandran, A., Sivasankari, S., Satyavani, K., & Viswanathan, V. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.388 · Cited by 29
Carreón‐Torres, E., Juárez-Meavepeña, M., Cardoso-Saldaña, G. C., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.047 · Cited by 29
Eiberg, S., Hasselstrøm, H., Grønfeldt, V., Froberg, K., Cooper, A. R., & Andersen, L. B. (2005) · Pediatric Exercise Science · doi:10.1123/pes.17.2.161 · Cited by 29
Bach‐Ngohou, K., Nazih, H., Nazih‐Sanderson, F., Zaïr, Y., Carrer, D. L., Krempf, M., & Bard, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801833 · Cited by 29
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo‐Asian patients
Barnett, A. H., Grant, P. J., Hitman, G. A., Mather, H. M., Pawa, M., Robertson, L., & Trelfa, A. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00925.x · Cited by 29
Kanauchi, M., Nakajima, M., Saito, Y., & Kanauchi, K. (2003) · Metabolism · doi:10.1053/meta.2003.50078 · Cited by 29
Pioglitazone‐induced hepatic injury in a patient previously receiving troglitazone with success
Nagasaka, S., Abe, T., Kawakami, A., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00712_4.x · Cited by 29
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
